Loading clinical trials...
Loading clinical trials...
A Pragmatic Trial Designed to Evaluate a New Critical Pathway for Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
Conditions
Interventions
Usual Care
Dalbavancin
Locations
11
United States
Maricopa Medical Center
Phoenix, Arizona, United States
Olive View-UCLA Medical Center
Sylmar, California, United States
Hartford Hospital
Hartford, Connecticut, United States
Tampa General Hospital
Tampa, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Start Date
November 29, 2016
Primary Completion Date
March 29, 2019
Completion Date
March 29, 2019
Last Updated
April 10, 2020
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions